Chromadex Corp Stock Price on October 23, 2024
| CDXC Stock | USD 7.59 0.13 1.74% |
Below is the normalized historical share price chart for Chromadex Corp extending back to June 24, 2008. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Chromadex Corp stands at 7.59, as last reported on the 27th of November, with the highest price reaching 7.75 and the lowest price hitting 7.15 during the day.
If you're considering investing in Chromadex Stock, it is important to understand the factors that can impact its price. Chromadex Corp is risky given 3 months investment horizon. Chromadex Corp secures Sharpe Ratio (or Efficiency) of 0.17, which signifies that the company had a 0.17% return per unit of risk over the last 3 months. We have analyzed and interpolated twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.61% are justified by taking the suggested risk. Use Chromadex Corp Mean Deviation of 3.97, downside deviation of 2.64, and Risk Adjusted Performance of 0.1316 to evaluate company specific risk that cannot be diversified away.
At present, Chromadex Corp's Sale Purchase Of Stock is projected to increase significantly based on the last few years of reporting. . At present, Chromadex Corp's Price To Operating Cash Flows Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price To Free Cash Flows Ratio is expected to grow to 16.16, whereas Price To Sales Ratio is forecasted to decline to 1.22. Chromadex Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 15th of July 2008 | 200 Day MA 3.3779 | 50 Day MA 4.61 | Beta 1.88 |
Chromadex |
Sharpe Ratio = 0.1748
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | CDXC | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 9.22 actual daily | 82 82% of assets are less volatile |
Expected Return
| 1.61 actual daily | 32 68% of assets have higher returns |
Risk-Adjusted Return
| 0.17 actual daily | 13 87% of assets perform better |
Based on monthly moving average Chromadex Corp is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Chromadex Corp by adding it to a well-diversified portfolio.
Price Book 16.535 | Enterprise Value Ebitda 276.9478 | Price Sales 6.2161 | Shares Float 49.4 M | Wall Street Target Price 7.96 |
Chromadex Corp Main Headline on 23rd of October 2024
Disposition of 82734 shares by Lee Jeong James of Chromadex ... by Lee Jeong James
Filed transaction by Chromadex Corp Officer Interim Cfo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Chromadex Corp Valuation on October 23, 2024
It is possible to determine the worth of Chromadex Corp on a given historical date. On October 23, 2024 Chromadex was worth 3.46 at the beginning of the trading date compared to the closed value of 3.46. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Chromadex Corp stock. Still, in general, we apply an absolute valuation method to find Chromadex Corp's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Chromadex Corp where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Chromadex Corp's related companies.
| Open | High | Low | Close | Volume | |
| 3.48 | 3.54 | 3.42 | 3.49 | 161,373 | |
10/23/2024 | 3.46 | 3.47 | 3.39 | 3.46 | 183,078 |
| 3.47 | 3.53 | 3.42 | 3.43 | 201,007 |
| Backtest Chromadex Corp | | | Chromadex Corp History | | | Chromadex Corp Valuation | Previous | Next |
Chromadex Corp Trading Date Momentum on October 23, 2024
| On October 24 2024 Chromadex Corp was traded for 3.43 at the closing time. The top price for the day was 3.53 and the lowest listed price was 3.42 . The trading volume for the day was 201 K. The trading history from October 24, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 0.87% . The overall trading delta against the current closing price is 65.32% . |
Chromadex Corp Fundamentals Correlations and Trends
By evaluating Chromadex Corp's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Chromadex Corp's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Chromadex financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Chromadex Corp Stock history
Chromadex Corp investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Chromadex is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Chromadex Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Chromadex Corp stock prices may prove useful in developing a viable investing in Chromadex Corp
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 75 M | 43.1 M | |
| Net Loss | -14.9 M | -15.6 M |
Chromadex Corp Quarterly Net Working Capital |
|
Chromadex Corp Stock Technical Analysis
Chromadex Corp technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Chromadex Corp Period Price Range
Low | November 27, 2024
| High |
0.00 | 0.00 |
Chromadex Corp cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Chromadex Corp November 27, 2024 Market Strength
Market strength indicators help investors to evaluate how Chromadex Corp stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Chromadex Corp shares will generate the highest return on investment. By undertsting and applying Chromadex Corp stock market strength indicators, traders can identify Chromadex Corp entry and exit signals to maximize returns
Chromadex Corp Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Chromadex Corp's price direction in advance. Along with the technical and fundamental analysis of Chromadex Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Chromadex to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1316 | |||
| Jensen Alpha | 1.06 | |||
| Total Risk Alpha | 0.0348 | |||
| Sortino Ratio | 0.4985 | |||
| Treynor Ratio | 0.4476 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Chromadex Stock analysis
When running Chromadex Corp's price analysis, check to measure Chromadex Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chromadex Corp is operating at the current time. Most of Chromadex Corp's value examination focuses on studying past and present price action to predict the probability of Chromadex Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chromadex Corp's price. Additionally, you may evaluate how the addition of Chromadex Corp to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |